Manuka Honey pollinated from the sacred Manuka Tree that only blooms 2-6 weeks per year and native to New Zealand has been used for wellness remedies for many centuries. The nectar of the Manuka flower gives Manuka Honey its unique non-peroxide activity properties. The UMF (Unique Manuka Factor) rating number represents the unique signature compounds
ensuring purity and quality. These compounds include the key markers of Leptosperin, DHA and Methylglyoxal (MGO).
Methylglyoxyl (MGO) is found predominantly in Manuka honey and is the main chemical responsible for antibacterial activities. This is also known as natural peroxide.
Dihydroxyacetone (DHA), is a chemical precursor of MGO and is stored in the nectar in Manuka also known as Leptospermum scoparium. The DHA levels are often still relatively high in freshly harvested honey. Over time, DHA naturally converts to MGO.
Professor Kato, discovered the UMF Honey Association (UMFHA) analysis in Manuka nectar and honey to be uniquely at high concentrations and identified it as a good chemical marker for determining the authenticity of Manuka honey.
Manuka Honey, a plant based superfood, is widely used to support digestive and immune health. It can help soothe coughs, allergies, sore throat, and skin care issues.
Certified UMF® Manuka Honey with a 10+ or higher rating is medical grade and therapeutic for the skin. It contains the beneficial compounds that provide Manuka’s unique topical antibacterial and health benefits, including support for wound healing, combatting staph infections (such as MRSA) and helping treat acne and scarring.
CBG is an abbreviation for cannabigerol. Cannabigerol, or CBG, is the mother cannabinoid found in cannabis, both hemp and marijuana.
CBG is a non-intoxicating cannabinoid. When consumed, it won’t cause any type of euphoric effects like THC.
CBG is the mother cannabinoid to form in cannabis plants that breaks down to CBD, CBC, and THC as the plant matures in growth and heated through decarboxylation.
CBG enhances the body and its functions by interacting with the endocannabinoid system within our bodies. Because it is non-psychoactive features, CBG has a shown to work as an analgesic, therapy for psoriasis, and as an antidepressant.
CBG is shown to be effective in treating glaucoma because it reduces intraocular pressure.
CBG was found to decrease inflammation in Inflammatory Bowel Disease (IBD).
In 2015, a Huntington’s Disease study found CBG protected neurons characterized by nerve cell degeneration in the brain.
Studies support CBG as an aide in cancer cell regeneration because it blocks receptors that cause cancer cell growth. CBG was reported to inhibit the growth specifically linked to colorectal cancer cells and tumors.
European research shows evidence that CBG is an effective antibacterial agent, particularly against methicillin-resistant Staphylococcus aureus (MRSA) microbial strains resistant to several classes of drugs.
Studies conducted in 2017 showed that a form of CBG was a very effective appetite stimulant. CBG tested as the best cannabinoid to inhibit muscle contractions, leading researchers to believe it may aid in bladder dysfunction disorders.
The endocannabinoid system keeps our bodies balanced in homeostasis. The endocannabinoid system has two types of cannabinoid receptors, CB1 and CB2. CBG is found to bind to both receptors, yet does not cause psycho activity classifying the cannabinoid under the hemp umbrella.
Havelka, Jacqueline. What is CBG (cannabigerol) & what does this cannabinoid do? (2017).
Niaz K, Maqbool F, Bahadar H, Abdollahi M. Health Benefits of Manuka Honey as an Essential
Constituent for Tissue Regeneration. Curr Drug Metab. 2017;18(10):881-892. doi:
10.2174/1389200218666170911152240. PMID: 28901255.
Johnston, M., McBride, M., Dahiya, D., Owusu-Apenten, R., & Nigam, P. S. (2018).
Antibacterial activity of Manuka honey and its components: An overview. AIMS microbiology,
4(4), 655–664. https://doi.org/10.3934/microbiol.2018.4.655